↓ Skip to main content

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Overview of attention for article published in Drug Design, Development and Therapy, July 2016
Altmetric Badge

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
Published in
Drug Design, Development and Therapy, July 2016
DOI 10.2147/dddt.s110425
Pubmed ID
Authors

Sachio Fushida, Jun Kinoshita, Masahide Kaji, Katsunobu Oyama, Yasuo Hirono, Tomoya Tsukada, Takashi Fujimura, Tetsuo Ohta

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 21%
Other 5 12%
Student > Master 5 12%
Student > Bachelor 4 9%
Student > Doctoral Student 3 7%
Other 3 7%
Unknown 14 33%
Readers by discipline Count As %
Medicine and Dentistry 11 26%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Biochemistry, Genetics and Molecular Biology 3 7%
Neuroscience 2 5%
Nursing and Health Professions 1 2%
Other 5 12%
Unknown 17 40%